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Non-typeable Haemophilus influenzae (NTHi) is a frequent cause of lower respiratory
tract infection in people with chronic obstructive pulmonary disease (COPD). Pellino
proteins are a family of E3 ubiquitin ligases that are critical regulators of TLR signaling and
inflammation. The aim of this study was to identify a role for Pellino-1 in airway defense
against NTHi in the context of COPD. Pellino-1 is rapidly upregulated by LPS and NTHi
in monocyte-derived macrophages (MDMs) isolated from individuals with COPD and
healthy control subjects, in a TLR4 dependent manner. C57BL/6 Peli1−/− and wild-type
(WT) mice were subjected to acute (single LPS challenge) or chronic (repeated LPS
and elastase challenge) airway inflammation followed by NTHi infection. Both WT and
Peli1−/− mice develop airway inflammation in acute and chronic airway inflammation
models. Peli1−/− animals recruit significantly more neutrophils to the airway following
NTHi infection which is associated with an increase in the neutrophil chemokine, KC, in
bronchoalveolar lavage fluid as well as enhanced clearance of NTHi from the lung. These
data suggest that therapeutic inhibition of Pellino-1 may augment immune responses in
the airway and enhance bacterial clearance in individuals with COPD.
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INTRODUCTION
COPD will be the third-leading cause of death worldwide by 2030 (1). Recurrent bacterial and viral
infections are a significant cause of comorbidity in COPD, resulting in accelerated decline in lung
function and posing a major economic and personal burden (2). The most common colonizing
microorganism is NTHi, found in the lower respiratory tract of 30% of individuals with COPD (3).
This, as well as the acquisition of new strains of NTHi, are important causes of acute exacerbations
and NTHi directly contributes to airway inflammation in disease (4–6). The primary cellular
immune response to NTHi is the alveolar macrophage (AM), but in COPD, they often fail to clear
bacteria from the airway (7). NTHi infection leads to a Toll-like receptor (TLR)-dependent immune
response in AMs, including the release of proinflammatory cytokines such as CXCL8 (8), which
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recruits neutrophils to the lung. Neutrophils are an early and
prominent component of the immune response in the lung to
NTHi infection, as exemplified in murine models (9) and TLR-
mediated neutrophil recruitment is likely to be an integral part of
the airway response to NTHi.
Pellino proteins are a family of E3 ubiquitin ligases that
play important roles in TLR signaling and human immunity
(10). Increased Pellino-1 expression is associated with persistent
bacterial infection of the airways (11). Pellino-1 knockout mice
develop normally but are protected from the adverse effects of
systemic administration of TLR3 and TLR4 agonists, and Pellino-
1 is shown to mediate endotoxin tolerance, further supporting
its importance in infection-related inflammation (12, 13). The
aim of this study was to identify a role for Pellino-1 in airway
defense against NTHi in the context of COPD. Here we show that
induction of Pellino-1 is part of the cellular response to NTHi
in vitro and negatively regulates bacterial clearance in vivo. Our
work suggests that Pellino-1 is a key component of the immune
response to NTHi in the airway and that therapeutically targeting
Pellino-1 may enhance immunity in patients with COPDwho are
at risk of infection induced exacerbations.
MATERIALS AND METHODS
Animals
All work involving animals was performed in accordance with the
Animal (Scientific procedures) Act 1986 and has been approved
by the Animal welfare and ethical review body at University
of Sheffield. Work was carried out under procedure project
license 40/3726 (David Dockrell). C57BL/6 Peli1−/− mice and
WT littermates (13) were maintained via het/het breeding in a
pathogen-free environment and were housed in shared cages.
For full details of maintenance and experimental procedures
see online Supplementary Methods File. COPD model: Mice
were intranasally exposed to 7µg LPS (E. coli O26:B6, Sigma-
Aldrich (St. Louis, MO) and 1.2 units elastase (Merck Millipore,
Burlington, MA) each week for four consecutive weeks as
previously described (14). Selected mice were treated with
PBS as controls. All mice were randomized into treatment
groups. On day 28 mice were subjected to bronchoalveolar
lavage (BAL). Cell-free BAL fluid (BALF) was prepared and cell
pellets were resuspended, counted using a haemocytometer and
cytocentrifuge slides generated. Neutrophils and macrophages
were identified based on cell morphology. COPDNTHi infection
model: Mice were treated with weekly LPS/elastase as described
above. On day 28 mice were infected with NTHi375 (15) (107
CFU i.n.) for 24 h. Following this, mice were subjected to
BAL as above and lungs homogenized to measure bacterial
viability by Miles and Misra viability counts. Acute lung injury
LPS model: Peli1−/− and WT mice were exposed to 7µg LPS
i.n. After 24 h mice were infected with NTHi375 (107 CFU
i.n.) for a further 24 h. Mice were subjected to BAL, lung
homogenisation and estimation of NTHi CFU counts as above.
Bone marrow derived macrophages (BMDMs) were prepared
as previously described (16). Bone marrow derived neutrophils
(BMDNs) were isolated by negative magnetic selection (EasySep
Mouse neutrophil enrichment kit, Stemcell Technologies) as per
TABLE 1 | Demographics of individuals with COPD and AMHC subjects.
Demographic COPD (n = 3) AMHC (n = 3)
Age (mean years) 61 63
Gender (m/f) 3/0 2/1
FEV1 % mean (range) 50.7 (30–71) 103 (87–113)
GOLD stage 2-3 NA
ICS No (3) No (3)
Smoking status Current (1), ex (2) Never (3)
FEV1, forced expiratory volume in 1 second; ICS, inhaled corticosteroids.
manufacturer’s recommendation. Following negative selection
neutrophil purity was typically>95%.
Human Subjects
Peripheral blood was taken from healthy volunteers, people
with a diagnosis of COPD, or age-matched healthy control
(AMHC) subjects with written informed consent as per the
declaration of Helsinki, and ethical approval in accordance with
the recommendations of the South Sheffield Research Ethics
Committee and the National Research Ethics Service Committee
Yorkshire and the Humber (17). See Table 1 for demographics of
individuals with COPD and AMHC subjects.
Monocyte-Derived Macrophage (MDM)
Isolation and Culture
Neutrophils and mononuclear cells were isolated by plasma-
Percoll gradient centrifugation from whole blood. MDMs were
differentiated over 7 days as previously described (18). Peli1 was
knocked down in MDMs using Dharmacon ON-TARGET plus
SMARTpoolTM siRNA and Lipofectamine 2000 (ThermoFisher
Scientific), according tomanufacturer’s instructions. Knockdown
of Pellino-1 protein was verified in each experiment by
Western Blotting.
Isolation and Culture of AMs From Human
Lung
The use of lung tissue was approved by the National
Research Ethics’ Service (REC ref:15/NW/0657) and informed
written consent was obtained. Macrophages were isolated from
resected non-lesional tissue by discontinuous Percoll gradient
sedimentation as previously described (19). Macrophages were
seeded and cultured overnight in media (RPMI 1640+10% FCS)
before LPS challenge.
Western Blotting
Proteins in whole cell lysates were separated by SDS-
polyacrylamide gel electrophoresis and transferred onto
PVDF membranes. Membranes were probed against antibodies
to Pellino-1, actin (Santa Cruz, Santa Cruz, CA), pStat-1 or
Stat-6 (Cell-Signaling Technology, Leiden, The Netherlands).
Measurement of KC
Cell free BALF and cell culture supernatant were subjected
to KC ELISA (Duoset, R&D Systems) as per manufacturer’s
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instructions. Formalin fixed lung sections from LPS/elastase
treated mice were subjected to immunohistochemistry for KC.
NTHi Intracellular Viability Assays
Cells were infected with NTHi375 (MOI 10) for either 1 h
(BMDNs) or 2 h (MDMs, BMDMs). Cells were lysed and viable
NTHi measured by Miles and Misra assay. In separate wells,
gentamicin [40µg/ml] was added for 30min to kill extracellular
bacteria following which lysates were made after a further 1 h
(neutrophils) or 2 h (MDMs, BMDMs) and viable intracellular
NTHi was assessed as above.
Data Analysis and Statistics
Data were analyzed by One-way ANOVA (with post-test)
or Students’ t-test as appropriate using GraphPad Prism 7
(GraphPad Software, San Diego, CA). Data are expressed as
mean ± SEM or mean ± SD, and significance was accepted
at p< 0.05.
FIGURE 1 | Macrophages upregulate Pellino-1 in response to LPS and NTHi. MDMs were stimulated with LPS [1ng/ml] or NTHi (MOI 10) (A) for 1-6 h. Cells were also
cultured in media for 6 h (control, A). MDMs differentiated from monocytes isolated from a COPD patient were treated with LPS at 1 or 100 ng/ml (B), or NTHi MOI 10
(C) over a time course of 24 h. MDMs from age-matched healthy control subjects (AMHC) were challenged with NTHi in matched experiments (C). Primary human
neutrophils were treated with LPS [1ng/ml] for 6 h (D). Lysates for all cells were prepared and subjected to Western blotting using antibodies to Pellino-1 (P1) or actin
(loading control). Densitometry was performed on independent donors/experiments and data are presented as mean ± SEM. Panel d is representative of 3
experiments. Statistically significant differences are indicated by *p ≤ 0.05.
Frontiers in Immunology | www.frontiersin.org 3 July 2019 | Volume 10 | Article 1721
Hughes et al. Pellino-1 Regulates Responses to NTHi
FIGURE 2 | NTHi-mediated upregulation of Pellino-1 occurs via TLR4. MDMs
were stimulated with NTHi (MOI 1 or 10), or media control for 6 h in the
presence (open bars) or absence (black bars) of the TLR4 antagonist LPS-RS
[1µg/ml]. Lysates were prepared and subjected to Western blotting using
antibodies to Pellino-1 (P1) or actin (loading control). Representative blot as
shown in inset. Densitometry was performed on 3 independent
donors/experiments and data are presented as mean ± SEM. Statistically
significant differences are indicated by *p ≤ 0.05.
RESULTS
Macrophages Upregulate Pellino-1 in
Response to LPS and NTHi via TLR4
Since Pellino-1 has known roles in TLR4 signaling in monocytes
(12), we explored Pellino-1 regulation in response to LPS and
NTHi. In MDMs from healthy subjects, Pellino-1 protein is
profoundly upregulated by LPS and NTHi (Figure 1A). This
was confirmed in MDMs prepared from people with COPD
and age-matched healthy control subjects (Figures 1B,C). Since
macrophage phenotype can be sensitive to in vitro differentiation
programmes, we also confirmed an LPS-dependent upregulation
of Pellino-1 in preliminary work in primary AMs isolated
from human lung (Supplemental Figure 1A). Primary human
neutrophils also express Pellino-1 (Figure 1D). In contrast,
Pellino-1 protein is not regulated by the Gram-positive
bacteria, Staphylococcus aureus and Streptococcus pneumoniae,
nor the TIR agonist IL-1β (Supplemental Figures 1B–D)
although MDMs released CXCL8 in response to these
stimuli (data not shown). Although LPS signals exclusively
via TLR4, NTHi can also activate TLR2 in macrophages.
Figure 2 shows that the TLR4 antagonist LPS-RS (20)
significantly reduces NTHi-induced upregulation of Pellino-1,
suggesting NTHi signals, at least in part, via TLR4 to induce
Pellino-1 expression.
Peli1−/− Mice Develop Airway
Inflammation in Models of COPD
To establish a role for Pellino-1 in lung inflammation and
infection, we adopted a murine model of COPD in Pellino-1
(Peli1−/−) knockout mice and WT littermates (13, 14). Peli1−/−
and WT mice were treated with LPS and elastase (or PBS
as control) once per week for 4 weeks. As expected, there
was an increase in inflammatory cells in the WT LPS/elastase
BALF compared to WT PBS treated mice (Figure 3A). The
proportion and absolute number of neutrophils (Figures 3B,C)
and macrophages (Figures 3D,E) in BALF was increased in WT
LPS/elastase mice compared to WT PBS animals. No significant
difference was observed between WT and Peli1−/− LPS/elastase
treated animals for either absolute number or proportion of
cells by type (Figures 3A–E). WT and Peli1−/− mice treated
with PBS were comparable for all cell counts (data not shown).
Lung histology from PBS-treated WT and Peli1−/− mice shows
no evidence of inflammation (Figure 3F, upper panels). Both
WT and Peli1−/− LPS/elastase-treated mice developed airway
inflammation, illustrated by an increase in cellularity and loss
of alveolar architecture consistent with emphysema (Figure 3F,
lower panels). These findings show that loss of Pellino-1 does not
impact on the development of airway inflammation in this model
at the timepoint studied.
Peli1−/− Mice Recruit More Neutrophils to
the Airway in Response to NTHi and Clear
the Infection More Effectively in Murine
Models of COPD
WT and Peli1−/− mice pre-treated with LPS/elastase were
infected with NTHi (or PBS as control. Both WT and Peli1−/−
micemounted an immune response to NTHi, as demonstrated by
an increase in absolute cell number in BALF (Figure 4A). There
was no significant difference in absolute cell number between
WT and Peli1−/− NTHi infected animals (Figure 4A). NTHi
infected Peli1−/− mice have proportionally more neutrophils
in BALF compared with WT (Figure 4B, lower panels and
Figures 4C,D). This was concomitant with a decrease in the
number of macrophages (Figures 4E,F). Neutrophil apoptosis
was assessed on BALF cytocentrifuge slides and there was no
difference between WT and Peli1−/− mice (Figure 4G). The
principal neutrophil chemokine, KC, was significantly increased
in BALF from Peli1−/− mice (Figure 4H). CFU counts from
homogenized lungs show fewer viable bacteria from Peli1−/−
mice compared to WT mice (Figure 4I). No viable bacteria were
grown from blood cultures (data not shown).
Increased Airway Neutrophilia in Peli1−/−
Mice Following Acute Lung Injury and NTHi
Infection
These findings were recapitulated in an LPS acute lung injury
model, which typically results in a more marked neutrophilic
inflammation (21). As before, the overall cell number in
BALF was not different between WT and Peli1−/− mice
(Figures 5A,B). Both the number and proportion of neutrophils
were significantly increased in Peli1−/−mice (Figures 5C,D) and
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FIGURE 3 | WT and Peli1−/− mice develop airway inflammation in response to repeated LPS and elastase. Peli1−/− transgenic mice and WT littermates were given
i.n. PBS (black circles) or LPS (7µg) and porcine neutrophil elastase (1.2 units, black squares) every 7 days for 4 weeks. Mice were subjected to bronchoalveolar
lavage (BAL) on day 28 and inflammation assessed by enumerating total cell number in BALF by haemocytometer (A) and number/proportion of neutrophils (B,C) and
macrophages (D,E) by light microscopy. Lungs were removed and stained for histological analysis. Representative images are shown (F, scale bar = 50µm).
Individual data points represent a single mouse and panels show mean ± SD. Statistically significant differences are indicated by *p < 0.05 (n = 3–5 A, n = 3–9 B–E).
concomitantly, the number and proportion of macrophages were
significantly decreased (Figures 5E,F). There was no difference
in the rate of neutrophil apoptosis in BALF between WT and
Peli1−/− mice (Figure 5G). A trend toward fewer viable NTHi
was observed in lungs of Peli1−/− mice compared to WT mice,
although this did not reach statistical significance, potentially
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FIGURE 4 | Peli1−/− COPD mice recruit more neutrophils following NTHi infection and clear NTHi more effectively compared to WT. Peli1−/− transgenic mice and
WT littermates were given i.n. LPS [7µg] and 1.2 units porcine neutrophil elastase every 7 days for 4 weeks. On day 28, mice were infected with 1 × 107 CFU NTHi.
(Continued)
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FIGURE 4 | After 24 h (day 29) lungs were lavaged and removed for homogenisation. Total cell number in BALF was enumerated by haemocytometer (A) and cell
differential determined by light microscopy of cytocentrifuge slides, scale bar = 50µm (B), Number/proportion of neutrophils (C,D) and macrophages (E,F) were
determined. Percentage of apoptotic neutrophils were scored on BALF cytocentrifuges by morphology (G). KC levels in BALF were measured by ELISA (H) and NTHi
CFU in homogenized lungs was determined by Miles Misra (I). Individual data points represent a single mouse and panels show mean ± SD. Statistically significant
differences are indicated by *p < 0.05 (n = 4–8 A, n = 5–8 C–F, n = 5-6 G (apoptosis), n = 3–4 h (KC), n = 7 I (NTHi)).
due to sample size (P = 0.056, Figure 5H). Overall, these
data suggest that suppression of Pellino-1 leads to improved
bacterial clearance.
Loss of Pellino-1 Does Not Impact on
Killing or Internalization of NTHi by
Neutrophils and Macrophages
Based on known roles for Pellino-1 in macrophage polarization
we next studied whether the enhanced clearance of NTHi in
Peli1−/− mice was due to promotion of a particular macrophage
phenotype (22). To do this we used an in vitro siRNA
approach in MDMs. STAT-1 and STAT-6 transcription factors
facilitate distinct macrophage phenotypes and are activated
by LPS/IFNγ and IL-4/IL-10, respectively (22, 23). IFNγ,
but surprisingly not LPS, upregulated phosphorylated STAT-
1 (pSTAT-1) (Figure 6A), which was significantly reduced
in cells transfected with Peli1 siRNA (Figure 6B). STAT1
is phosphorylated following TLR2 and TLR4 activation in
macrophages (24) and here we show that NTHi induces pSTAT-
1, which is reduced in Peli1 siRNA transfected cells (Figure 6C).
IL-4 failed to upregulate STAT-6 (Figure 6A) therefore we
measured CD206 expression, which is regulated by STAT-6,
and show it is upregulated by IL-4, but unaffected by Peli1
knockdown (Figure 6D).
These data suggest that loss of Pellino-1 does not promote
an anti-microbial macrophage phenotype. This was confirmed
in NTHi killing assays where both scrambled and Peli1 siRNA
transfected MDMs were able to internalize (assayed at 2 h) and
entirely eradicate (assayed at 4 h) NTHi to a comparable degree
(Figure 7A). This was supported in BMDMs prepared from
WT and Peli1−/− mice (Figure 7B). Murine macrophages are a
source of KC and synthesis of this chemokine occurs via TLR-
mediated pathways. Histology on lung sections from LPS/elastase
treated WT and Peli1−/− mice show individual cells staining
for KC (Figure 7C). Since these cells were of a macrophage
like appearance and since we measured increased KC in BALF
from Peli1−/− mice (Figure 4D), we investigated KC production
from BMDMs fromWT and Peli1−/− mice. Figure 7D shows no
difference in NTHi-induced KC production by Peli1−/− BMDMs
compared to WT.
Since Peli1−/− macrophages were no more effective at
killing NTHi in vitro, we hypothesized that it is the increased
neutrophil number in the lung of Peli1−/− mice that results
in enhanced bacterial clearance. Neutrophils can phagocytose
and destroy NTHi (8) and we examined whether Pellino-
1 knockout impacted on this neutrophil function. No viable
bacteria were recovered from either WT nor Peli1−/− bone
marrow-derived neutrophils at any timepoint studied, despite
being able to visualize NTHi inside these cells (Figure 7E).
These data demonstrate that despite loss of Pellino-1, neutrophils
rapidly and completely kill internalized NTHi, and suggest it is
feasible that increased neutrophil number in Peli1−/− mice leads
to better clearance of NTHi.
DISCUSSION
We show that human macrophages rapidly and profoundly
upregulate Pellino-1 in response to LPS and NTHi, suggesting
a potential role for this protein in the initial cellular immune
response to NTHi. In in vivo models of acute and chronic
inflammation, Peli1−/− mice recruit more neutrophils to the
airway following NTHi challenge, compared toWT animals. This
is accompanied by an increase in the neutrophil chemoattractant
KC in BALF. Peli1−/− mice clear NTHi more effectively from
the lung than WT littermates, which may be as a result of
the increased neutrophilic immune response in the airway.
Our work suggests that Pellino-1 is a key component of the
airway immune response to NTHi and that therapeutically
targeting Pellino-1 may enhance clearance of NTHi in patients
with chronic inflammatory disease who are at risk of infection
induced exacerbations.
Pellino-1 interacts with TIR signaling pathways at various
points due to its ability to bothmark proteins for degradation (via
K48-linked ubiquitination) and initiate downstream signaling
(via K63-linked ubiquitination) (25, 26). It has both negative and
positive regulatory roles on signaling, depending on the cell type
and stimulus (27, 28). Our previous work identifies a role for
Pellino-1 in epithelial cell responses to rhinoviral infection (29)
and this along with a growing literature on roles for Pellino-
1 in infection (30), led us to hypothesize that loss of Pellino-
1 would impact on responses to the airway pathogen, NTHi.
The initial cellular immune response to NTHi is predominantly
mediated by AMs, followed by recruitment of neutrophils, which
primarily function during acute infective exacerbations (8, 31).
Studies have shown that macrophages from people with COPD
are defective in phagocytosing NTHi (32). Since healthy lungs are
mostly resistant to NTHi infection and murine models also show
rapid clearance, we adopted a murine model of COPD, which
better mimics host-pathogen interactions in patients with this
disease (33). LPS/elastase-induced lung inflammation occurred
irrespective of genotype. This suggested that although Pellino-
1 is a component of the TLR4 pathway it was not essential for
mediating inflammatory signals via LPS in this context, perhaps
indicating some functional redundancy in this pathway. NTHi
infection resulted in additional neutrophil recruitment to the
lung, confirming findings from similar studies (33), and which
is observed in people with COPD colonized with NTHi (34).
Peli1−/− mice had more neutrophils and fewer macrophages
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FIGURE 5 | Peli1−/− acute lung injury mice recruit more neutrophils following NTHi infection and clear NTHi more effectively compared to WT. Peli1−/− transgenic
mice and WT littermates were given a single treatment of i.n. LPS [7µg] (day 1). After 24h mice were infected with 1x107 CFU NTHi (day 2). After 24h (day 3) lungs
were lavaged and subsequently removed for homogenisation. Total cell number in BALF was enumerated by haemocytometer (A) and cell differential determined by
light microscopy of cytocentrifuge slides, scale bar = 50µm (B). The number/proportion of neutrophils (C,D) and macrophages (E,F) were determined. Percentage of
apoptotic neutrophils were scored on BALF cytocentrifuges by morphology (G). NTHi CFU in homogenized lungs was determined by Miles and Misra method (H).
Individual data points represent a single mouse and panels show mean ±SEM. Statistically significant differences are indicated by *p < 0.05, **p < 0.01, ****p <
0.0001 n = 6 A, n = 5–6 C–F, n = 3–4 G (apoptosis) n = 6-7 D (NTHi).
in BALF, which may in part be accounted for by an increase
in KC. The source of the KC is not clear, and while resident
tissue macrophages are thought to be a principal source of KC
in the murine lung, epithelial cells also produce this chemokine
in concert with airway myeloid cells following infection (35).
Lung histology images suggest cells with a macrophage-like
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FIGURE 6 | Pellino-1 regulates macrophage STAT-1 signaling. MDMs were transfected with siRNA targeting Pellino-1 or scrambled siRNA (control). (A,B,D) 48 h
following transfection, cells were stimulated with IFN-γ [20 ng/ml], IL-4 [20 ng/ml], IL-10 [20 ng/ml] or LPS [1 ng/ml] for 24 h. Whole cell lysates were analyzed by
Western blot using antibodies specific to STAT-1, pSTAT-6, Pellino-1 or actin for 4 independent donors (A). pSTAT-1 bands for IFN-γ-treated cells were analyzed by
densitometry (B). In separate experiments cells were challenged with NTHi (MOI 1 and 10) for 24 h and lysates probed for Pellino-1 and actin (C). RNA was purified
from cell lysates and transcribed to cDNA. CD206 gene product was measured by qPCR (D). Fold changes are shown relative to media treated MDMs transfected
with scrambled siRNA (first open bar). Data are presented as mean ± SEM of n = 4 independent experiments. Significant differences are indicated by **P < 0.01.
morphology rather than epithelial cells appear to be more
intensely stained for KC. Peli1−/− BMDMs show a trend for
increased KC production in response to NTHi in vitro, although
this is not statistically significant, but may indicate a negative
regulatory role for Pellino-1. Although Pellino-1 has previously
been identified as a positive regulator of macrophage TLR
signaling (27), it negatively regulates T cell activation (28).
Th17 cells play an important role in neutrophil recruitment
to the airway following NTHi infection (31), and heightened
T cell activation in Peli1−/− mice may be the cause of the
airway neutrophilia we see in our model. Pellino also negatively
regulates immunity in Drosophila and ablation of Pellino in
adult flies promotes clearance of Micrococus luteus (36). A
similar role has been described for Pellino-3, where knockdown
results in increased inflammatory cytokine production following
bacterial infection of macrophages (12). Evidence for Pellino-1
in the negative regulation of inflammation is found in a murine
ischemic skin flap study, where Pellino-1 overexpression leads to
reduced infiltration of inflammatory lymphocytes to the dermis
and faster resolution of inflammation (37).Moreover, the Smad-6
interacting peptide, Smaducin-6, disrupts Pellino-1 signaling and
has been shown in murine models of sepsis to improve bacterial
clearance via increased neutrophil recruitment, supporting a role
for Pellino-1 in negatively regulating immunity in the context
of bacterial infections (38). Our findings may suggest a way to
improve immunity in patients with COPD, which may be made
possible by development of tools such as Smaducin-6. These
observations are also interesting in that reducing neutrophilic
inflammation because of its lung damaging potential in COPD
is often considered to be a plausible therapeutic target: our data
indicate that in people with chronic infection, reduction in lung
neutrophil numbers may not always be a desirable aim. Whether
inducing an airway neutrophilia is detrimental for patients with
inflammatory disease in this way would need further study.
In our models, it is most likely that increased bacterial
clearance is consequent upon neutrophil recruitment, since we
did not show increased monocyte recruitment. Furthermore,
although we showed some decrease in polarization markers in
Pellino-1 knockout macrophages, macrophage killing of NTHi
was unimpaired. Others have shown that Pellino1 promotes
macrophage polarization in vitro, which is in support of
the STAT-1 downregulation we observed in Pellino1 siRNA
transfected MDMs (39). We would therefore expect loss
of Pellino1 to result in impaired killing of NTHi, but we
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FIGURE 7 | Internalization and killing of NTHi is not impaired by loss of Pellino-1. (A) MDMs were transfected with siRNA targeting Pellino-1 or scrambled siRNA
(control). 48 h following transfection, MDMs were infected with NTHi (MOI 10) for 2 h after which cells were lysed and viable intracellular bacteria enumerated by Miles
Misra (2 h, black squares). In parallel wells, MDMs were treated with gentamycin to kill extracellular bacteria for a further 2 h, after which intracellular NTHi were
enumerated by Miles Misra (4 h, open circles). (B) WT and Peli1−/− BMDM were infected with NTHi (MOI 5) and viable bacteria enumerated at 2 and 4 h as above.
(C) Lung sections from WT and Peli1−/− mice treated with LPS/Elastase were subjected to histology and immunostained for KC. Zoomed inset shows individual cells
staining for KC in brown. (D) Day 14 WT and Peli1−/− BMDM were infected with NTHi (MOI 5) for 24 h and cell free supernatants subjected to KC ELISA.
(E) neutrophils were isolated from WT and Peli1−/− BMDM and infected with NTHi (MOI 10) for 1h. Cytocentrifuge slides were prepared and arrows point to
neutrophils containing NTHi. Zoomed inset highlights NTHi within intracellular vacuoles. Data are expressed as individual points with mean±SEM (A, n = 7) or mean
(B, n = 2) or as bars (C, mean±SEM, n = 3–5).
could not find a difference in the internalization or killing
capacity of Pellino1 deficient human or murine macrophages,
which may indicate eradication of NTHi occurs irrespective of
polarization state.
We show Pellino-1 expression is linked to TLR4 signaling
and our data support previous studies showing Pellino-1 is
regulated in response to LPS (12). TLR4 knockout mice have
reduced inflammation and impaired bacterial clearance during
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NTHi infection, further supporting a role for neutrophils in the
eradication NTHi (40, 41). In Drosophila, ablation of Pellino in
adult flies promotes clearance of bacteria (36), in comparison
with Toll mutant flies who are profoundly vulnerable to infection
(42). Taken together, these studies and our work indicate that
Pellino-1 knockdown in a whole organism is associated with
increased bacterial clearance, preserved antimicrobial signaling,
and better induction of effective innate immunity. In conclusion,
we demonstrate a role for Pellino-1 in mediating immune
responses in the airway and suggest that therapeutic inhibition of
Pellino-1 may enhance bacterial clearance in people with COPD.
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